ArticleMultiple sclerosis journal - experimental, translational and clinical

Metabolic labeling kinetics of brain-derived 24S-hydroxycholesterol in blood in multiple sclerosis: Effects of treatment with the remyelinating antibody rHIgM22.

Mahalakshmi Shankaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.